Atlas Trials

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma

Clinical trial NCT02489695 · COMPLETED

Trial details

NCT number
NCT02489695
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Papillary Renal Cell Carcinoma
Start date
2015-10-01
Primary completion
2019-07-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.